Apr. 2021 | Oncimmune announces the signature of Agreements with Roche and Cedars-Sinai to profile patients using Oncimmune’s novel Infectious Disease panel
Mauna Kea Technologies (Euronext: MKEA) inventor of Cellvizio®, the multidisciplinary probe-based and needle-based confocal laser endomicroscopy (pCLE/ nCLE ) platform…